Acadia Healthcare Company, Inc. (ACHC)
NASDAQ: ACHC · Real-Time Price · USD
23.91
+0.07 (0.29%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Acadia Healthcare Company Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Acadia Healthcare Company stock have an average target of 54.45, with a low estimate of 35 and a high estimate of 91. The average target predicts an increase of 127.73% from the current stock price of 23.91.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Acadia Healthcare Company stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 4 | 4 | 4 | 5 |
| Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Hold | 4 | 3 | 2 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Initiates $36 | Strong Buy | Initiates | $36 | +50.56% | Apr 9, 2025 |
| Mizuho | Mizuho | Hold Maintains $48 → $37 | Hold | Maintains | $48 → $37 | +54.75% | Mar 25, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $64 → $43 | Buy | Maintains | $64 → $43 | +79.84% | Mar 3, 2025 |
| Keybanc | Keybanc | Buy Maintains $70 → $65 | Buy | Maintains | $70 → $65 | +171.85% | Mar 3, 2025 |
| Barclays | Barclays | Buy → Hold Downgrades $43 → $35 | Buy → Hold | Downgrades | $43 → $35 | +46.38% | Feb 28, 2025 |
Financial Forecast
Revenue This Year
3.40B
from 3.15B
Increased by 7.93%
Revenue Next Year
3.70B
from 3.40B
Increased by 8.58%
EPS This Year
2.77
from 2.78
Decreased by -0.31%
EPS Next Year
3.17
from 2.77
Increased by 14.25%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.5B | 3.9B | 4.2B | ||
| Avg | 3.4B | 3.7B | 4.0B | ||
| Low | 3.2B | 3.5B | 3.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 11.9% | 14.0% | 13.6% | ||
| Avg | 7.9% | 8.6% | 7.9% | ||
| Low | 2.5% | 1.6% | 0.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.78 | 4.36 | 3.62 | ||
| Avg | 2.77 | 3.17 | 3.23 | ||
| Low | 2.45 | 2.61 | 2.78 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 36.0% | 57.2% | 14.4% | ||
| Avg | -0.3% | 14.3% | 2.0% | ||
| Low | -11.9% | -5.9% | -12.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.